# Are GLP-1s the New Statins? > Cardiologists say Ozempic protects the heart in ways that have little to do with the number on the scale. - Title: Are GLP-1s the New Statins? · Men's Health | Shortify - Summary: Cardiologists say Ozempic protects the heart in ways that have little to do with the number on the scale. GLP-1s and statins fix different drivers of heart… - Keywords: glp-1, heart health, statins, cholesterol, metabolic health, GLP-1s, Men's Health - Source: Men's Health — https://menshealth.com/health/a73741888/are-glp-1s-the-new-statins-heart-health - Author: Andi Breitowich - Published: 2026-09-15T19:29:00+00:00 - Read time: 2 min - Topics: glp-1, heart health, statins, cholesterol, metabolic health ## A quadrupled prescription GLP-1 use has jumped four times over in the past few years, and the benefits keep showing up in places that have nothing to do with weight. ## The heart signal is strongest Of everything researchers have looked at beyond weight, the cardiovascular findings are the steadiest. They start to look a lot like what statins deliver. ## People actually take them Statins have run cardiovascular care for decades but carry a reputation for muscle side effects. GLP-1s have the opposite problem: demand. > With one glaring difference: people actually want to take GLP-1s. ## Not a cage match With the most promising new cholesterol drug failing, the obvious question is whether GLP-1s take over. Cardiologists say both drugs keep their spot. ## Two different jobs GLP-1s copy a hormone that regulates blood sugar, appetite and fullness. Statins block a liver enzyme to drop LDL and slow plaque buildup. ## Foundation plus metabolism Arash Bereliani, MD, tells patients to picture the statin as the base layer and the GLP-1 as the metabolic partner. For the right person, both cover more ground. > I tell patients to think of the statin as the foundation for cholesterol and the GLP-1 as handling the metabolic side. ## Different positions, same team Fadi Alameddine, MD, puts numbers on it: statins cut LDL 30 to 50 percent with 30-plus years of proof. GLP-1s barely move LDL and work everywhere else. > Statins drop LDL cholesterol by 30 to 50 percent... GLP-1s barely touch LDL. ## Inflammation cools fast In a large NEJM trial, semaglutide lowered hs-CRP, an inflammation marker, within four to eight weeks. The drop showed up before meaningful weight loss, and even in people who lost none. > These drugs seem to protect the heart in ways that aren't just about the weight coming off. ## Blood vessels loosen up GLP-1s appear to improve the endothelium, the lining inside your vessels, and raise nitric oxide. Vessels stay flexible and shed some oxidative stress. > A healthier lining is a lining that resists plaque. ## Blood pressure ticks down Expect a few points, mostly from weight loss easing strain on the system. The kidneys may also dump more sodium, which pulls fluid out of circulation. ## A cleaner metabolic panel Triglycerides fall, HDL nudges up, and blood sugar improves a lot. One study found semaglutide users were 73 percent less likely to develop diabetes than placebo. > GLP-1s clean up your metabolic profile. ## Fat around the heart shrinks Along with visceral fat, GLP-1s reduce epicardial fat, the layer sitting right on the heart. That fat is metabolically active and pumps out inflammatory compounds. ## The gut is the hook Men show up worried about weight and energy, not cholesterol numbers. Bereliani uses that as the opening, because belly fat is what is driving the risk anyway. > A lot of guys are more motivated by losing the gut than by some cholesterol number I put in front of them. ## Still not a magic bullet No GLP-1 replaces sleep, exercise, decent food, or the other heart medications a patient may need. It is a tool, not a substitute. > They don't replace sleep, exercise, and eating right. ## Match the drug to the driver High LDL or existing plaque points straight to a statin. Obesity, prediabetes and a 44-inch waist point to a GLP-1. Line the treatment up with what is fueling the risk. > It's not one medication replacing the other. ## Key takeaway GLP-1s and statins fix different drivers of heart risk, so the right drug depends on whether your problem is cholesterol or metabolism.